Day one:
Tuesday 24 February 2009 |
| 08:30 |
|
Registration |
| 08:50 |
Henk Mollee
Director CTM Supply and Operations
Astellas Pharma |
Opening remarks from the Chair
|
| Successfully managing the clinical supply chain |
| 09:00 |
Mike Dey
Vice President,
Pharmaceutical Development
Ipsen |
Evaluating the performance of the CTS processes using KPIs
- Establishing accurate KPIs
- Calculating the success of the supply chain as a whole
- Ensuring successful supply chain management
|
| 09:30 |
Wade Wirta
Vice President, IVRS
Perceptive Informatics |
Efficient supply chain management through integrated e-clinical solutions
- Controlling waste by applying advanced re-supply techniques
- Limiting distribution costs
- Improving supply tracking and monitoring
|
| 10:00 |
Michael Richter
Global Clinical Trial Coordinator
Roche |
Simulating optimal clinical drug supply
- Assessing the tools and techniques
- Practical examples: successes and challenges
- Ensuring an accurate drug supply throughout the clinical trial
|
| 10:30 |
|
Morning refreshments |
| 11:00 |
Ed Tourtellotte
President and CEO
Tourtellotte Solutions |
Comparing forecasting methods against real clinical trials
- Reviewing different forecasting techniques
- Contrasting forecast models and real time clinical trials
- Analysing the most accurate forecasting methods
|
| 11:30 |
Angelique Keijzer
Clinical Support Manager
Sanofi Aventis |
Exploring CTS: an end user’s perspective
- Taking the needs of the end user into account when setting up the supply chain
- Pitfalls at the end of the supply chain
- Maximising IVRS efficiency and compliance at the user’s level
|
| Focusing on investigator initiated trials |
| 12:00 |
Michael Stephenson
Head of IMSC Europe
Celgene |
EU investigator initiated trials: material supply challenges, a perspective
- Different approaches to material supply for EU IITs
- Forecasting and planning: is it possible to get accurate information?
- Distribution: single or multiple shipments?
|
| Meeting the challenges of global clinical trials head-on |
| 12:30 |
Mark Woolf
Global Depot Manager
Almac |
Practicalities of global depot management
- Ever expanding clinical horizons
- Considerations prior to study commencement
- Best supply chain management practices
- Focusing on controlled substance and cold chain IMP's
|
| 13:00 |
|
Lunch |
| 14:00 |
Ying Zhang-Marainen
Director, Clinical Trial Supply Chain Services Business Development - Asia Pacific
Worldcourier |
Reviewing CTS in emerging countries
- Exploring the challenges and trends
- Difficulties in handling investigational drugs
- What the sponsors and CROs are looking for
- Detailing the benefits of in-country solutions
- Case study: Overcoming regulatory hurdles in China
|
| 14:30 |
Angus Cameron
Director
Pharmarama |
Sourcing comparators for clinical trials in India
- Exploring the Indian pharma market
- Challenges of procuring comparator drugs
- Reviewing the necessary documentation needed
- Managing the logistics and security of supplying lines
|
| Exploring outsourcing aspects of the clinical supply chain |
| 15:00 |
Anja van Strien
Head Section Investigational Products Supply-Logistics
Schering-Plough |
Developing and maintaining a successful sponsor/service provider relationship
- Vendor selection and management
- Clear agreements to avoid pitfalls
- Establishing a personal relationship
|
| 15:30 |
Claude Ammann
Director, Quality Assurance/Quality Control
Topotarget |
Case study: deciding to outsource or work in-house
- Examining internal core competencies
- Objectifying the reasons to outsource
- Taking a long term strategic view
- Communicating with the key players
- Making the decision
|
| 16:00 |
|
Afternoon refreshments |
| Streamlining the distribution network |
| 16:20 |
Angus MacLeod
Senior Manager, Global Depot Network
Aptuit Ltd |
Challenges to controlled drug distribution
- Exploring facility licenses to store and distribute narcotic clinical trial materials
- Moving clinical trial materials between countries
- Analysing different country requirements for different schedules of controlled drugs
|
| 16:50 |
Richard Nelson
Clinical Supplies Specialist
AstraZeneca |
Analysing and implementing clinical trials distribution direct to site
- Why adopt this strategy?
- Assessing the regulatory challenges
- Selecting the best providers
- Cost vs. lead time benefits
|
| 17:20 |
|
Closing remarks from the Chair and end of day one |
| 17:30 |
|
Drinks reception sponsored by Almac |
Day two:
Wednesday 25 February 2009 |
| 08:30 |
|
Registration and coffee |
| 09:00 |
Dr. Mike Hutton
Client Development Lead
Almac |
Opening remarks from the Chair |
| 09:10 |
Roundtable morning |
Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to a current aspect of clinical trial supply. |
| |
|
|
|
|
|
|
| 1 |
Packaging for clinical trials: producing cost effective kits
Robert Smith
Director of Clinical Pharmacy Research Services, Quality Assurance and Qualified Person
Genzyme |
2 |
Understanding the different challenges which need to be met when packaging and labelling for trials in emerging countries
Heike Roeder
Director, Global Head of Clinical Trial Supply Planning
UCB |
3 |
Ensuring investigational products are transported at the correct temperature
Lene Bastholm
Clinical Trial Supply Coordinator
Nycomed |
|
| |
|
|
|
|
|
|
| 4 |
Working towards a flexible supply chain to ease adaptive trial design
Henk Mollee
Director, CTM Supply and Operations
Astellas Pharma and
Michael Herschel
Director of Clinical Research
GlaxoSmithKline |
5 |
Taking clinical, regulatory and sponsor requirements into account to ensure patient compliance when preparing clinical supplies
Hansjoerg Nortmeyer
Supply Chain Trial Manager
Sanofi Aventis |
6 |
Managing expiration to destruction: looking for new tools in the clinical trial supply chain
Dr. Mike Hutton
Client Development Lead
Almac |
|
| |
|
|
|
|
|
|
|
| 12:30 |
|
Lunch |
| Ensuring patient compliance |
| 13:40 |
Dr David Spackman
Director,
Healthcare Packaging (Europe)
MWV |
Patient adherence in the clinic: myth or truth?
- Focusing on the consequences and costs of sub-optimal adherence
- Packaging driven strategies to measure and optimise outcomes
- Best practice techniques to ensure patient adherence
|
| Overcoming packaging and labelling issues for CTS |
| 14:10 |
Sascha Sonnenberg
Head of Sales and Marketing
Faubel |
Supplying multilingual labels for increasingly global clinical trials
- Constructing a multilingual label
- Establishing efficient processes to achieve the best results
- Meeting a wide range of regulations in one design
|
| 14:40 |
Robert Smith
Director of Clinical Pharmacy Research Services, Quality Assurance and Qualified Person
Genzyme |
Tackling packaging challenges for clinical trials
- The need for compliant packaging with maximum flexibility for modification
- Assessing outsourcing to contract manufacturers
- Producing cost effective clinical trial kits
|
| 15:10 |
|
Afternoon refreshments |
| Looking to the future: CTS with adaptive trials |
| 15:30 |
Henk Mollee
Director,
Clinical Supply and Operations
Astellas Pharma |
Modifying the clinical supply chain to accommodate adaptive trials
- Understanding how adaptive trials will impact on CTS
- Adjusting current procedures to facilitate adaptive trials
- Ensuring flexibility in the supply chain to support adaptive trial design
|
| 16:00 |
Michael Herschel
Director,
Clinical Research
GlaxoSmithKline |
Adaptive trial design: optimising the clinical supply process
- Analysing adaptive trial impact on trial management
- Reviewing drug production and inventory strategies and drug supply implications
- Resource needs for adaptive trial designs
- Cost of adaptive design trial drug supplies (vs standard design trials)
|
| 16:30 |
|
Closing remarks from the Chair and Champagne prize draw |
| 16:40 |
|
End of conference |